Literature DB >> 23136618

Reduced expression of mir15a in the blood of patients with oral squamous cell carcinoma is associated with tumor staging.

João Artur Ricieri Brito1, Carolina Cavaliéri Gomes, Flávio Juliano Garcia Santos Pimenta, Alvimar Afonso Barbosa, Marco Antônio Máximo Prado, Vânia Ferreira Prado, Marcus Vinícius Gomez, Ricardo Santiago Gomez.   

Abstract

MicroRNAs (miRNAs) mir15a and let7a are important regulators of bcl-2, ras and c-myc proteins. Considering that these miRNAs are commonly altered in many human cancers and that these proteins are reported to be altered in oral squamous cell carcinoma (OSCC), we investigated them in a set of OSCC cases. The miRNAs as well as the proteins were evaluated in the tumor and blood of 20 patients by real-time quantitative PCR and immunohistochemistry, respectively. The expression of mir15a and bcl-2 proteins in the tumors was not associated with each other or with tumor staging. On the other hand, we found reduced expression of this miRNA in the blood of patients with an advanced stage of OSCC and with lymph node metastasis. The expression of let7a in the tumor and blood was not associated with tumor size, lymph node metastasis, tumor staging and immunoexpression of ras and c-myc proteins. In conclusion, the present study shows that reduced expression of mir15a is associated with OSCC staging.

Entities:  

Keywords:  let7a; microRNA; mir15a; oral cancer

Year:  2010        PMID: 23136618      PMCID: PMC3490345          DOI: 10.3892/etm_00000035

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNA and oral cancer: future perspectives.

Authors:  Carolina C Gomes; Ricardo S Gomez
Journal:  Oral Oncol       Date:  2008-07-11       Impact factor: 5.337

Review 3.  Global epidemiology of oral and oropharyngeal cancer.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

Review 4.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

5.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

6.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Tomoki Naoe
Journal:  Biol Pharm Bull       Date:  2006-05       Impact factor: 2.233

7.  MicroRNA expression profiles in head and neck cancer cell lines.

Authors:  Nham Tran; Tessa McLean; Xiaoying Zhang; Chuan Jia Zhao; John Michael Thomson; Christopher O'Brien; Barbara Rose
Journal:  Biochem Biophys Res Commun       Date:  2007-04-09       Impact factor: 3.575

8.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

9.  Allelic loss of chromosome 13q14.3 in human oral cancer: correlation with lymph node metastasis.

Authors:  K Ogawara; A Miyakawa; M Shiba; K Uzawa; T Watanabe; X L Wang; T Sato; H Kubosawa; Y Kondo; H Tanzawa
Journal:  Int J Cancer       Date:  1998-08-21       Impact factor: 7.396

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  6 in total

Review 1.  MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.

Authors:  Min Cao; Lijuan Zheng; Jianzhou Liu; Thomas Dobleman; Shen Hu; Vay Liang W Go; Ge Gao; Gary Guishan Xiao
Journal:  Clin Oral Investig       Date:  2018-01-03       Impact factor: 3.573

2.  MiR-15a suppresses hepatocarcinoma cell migration and invasion by directly targeting cMyb.

Authors:  Bo Liu; Ting Sun; Gang Wu; Hui Shang-Guan; Zhao-Jin Jiang; Ji-Ren Zhang; Yan-Fang Zheng
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.

Authors:  Cornelia Lerner; Silke Wemmert; Florian Bochen; Philipp Kulas; Maximilian Linxweiler; Andrea Hasenfus; Joana Heinzelmann; Petra Leidinger; Christina Backes; Eckart Meese; Steffi Urbschat; Bernhard Schick
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-30       Impact factor: 4.553

4.  Bioinformatics analyses combined microarray identify the deregulated microRNAs in oral cancer.

Authors:  Jing Cui; Dalu Li; Wenmei Zhang; Liang Shen; Xin Xu
Journal:  Oncol Lett       Date:  2014-04-15       Impact factor: 2.967

5.  Distinctive pattern of let-7 family microRNAs in aggressive carcinoma of the oral tongue in young patients.

Authors:  Ohad Hilly; Nir Pillar; Sagit Stern; Yulia Strenov; Gideon Bachar; Noam Shomron; Thomas Shpitzer
Journal:  Oncol Lett       Date:  2016-07-20       Impact factor: 2.967

6.  Effect of Intrauterine Smoke Exposure on microRNA-15a Expression in Human Lung Development and Subsequent Asthma Risk.

Authors:  Sunita Sharma; Alvin T Kho; Divya Chhabra; Kathleen Haley; Carrie Vyhlidal; Roger Gaedigk; J Steven Leeder; Kelan G Tantisira; Benjamin Raby; Scott T Weiss
Journal:  Healthcare (Basel)       Date:  2020-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.